Dr. Lisa Rosina Carchedi, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 501 S Union Ave, Dept Of Behavioral Health, Havre De Grace, MD 21078 Phone: 443-843-8050 Fax: 443-843-6088 |
Joseph Gregory Hobelmann, M.D. Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Tydings Ln, Havre De Grace, MD 21078 Phone: 410-273-2261 |
Adam Rosenblatt, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 501 S Union Ave, Havre De Grace, MD 21078 Phone: 443-843-8050 Fax: 443-843-6088 |
Dr. Ralph Dalton Scoville, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 626 Revolution St, Havre De Grace, MD 21078 Phone: 410-939-8744 Fax: 443-502-2633 |
News Archive
The launch of the International Genomics of Alzheimer's Project (IGAP) - a collaboration formed to discover and map the genes that contribute to Alzheimer's disease - was announced today by a multi-national group of researchers including Drs. Lindsay Farrer and Sudha Seshadri at Boston University School of Medicine (BUSM). The collaborative effort, spanning universities from both sides of the Atlantic, will combine the knowledge, staff and resources of four consortia that work on Alzheimer's disease genetics.
The researchers, from the Liggins Institute at the University of Auckland, found that bone retains a "memory" of exercise's effects long after the exercise is ceased, and this bone memory continues to change the way the body metabolizes a high-fat diet, and published these results in Frontiers in Physiology.
CQ Politics reports on new legislation to subject insurers to antitrust laws: "The chairman of the Senate Judiciary Committee on Thursday introduced legislation to repeal health and medical malpractice insurers' exemption from federal antitrust laws.
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells- known as the PI3 kinase (PI3K) pathway-but efforts to develop therapies targeting this pathway have met with little success after hundreds of mostly failed clinical trials. And researchers still don't understand why.
› Verified 1 days ago